throbber
GASTROENTEROLOGY 1996;110:1595–1604
`
`g-Aminobutyric Acid Secretion From Pancreatic
`Neuroendocrine Cells
`
`GUDRUN AHNERT–HILGER,* ADELE STADTBA¨UMER,* CARSTEN STRU¨ BING,‡ HANS SCHERU¨ BL,*
`GU¨ NTER SCHULTZ,‡ ERNST–OTTO RIECKEN,* and BERTRAM WIEDENMANN*
`*Medizinische Klinik und Poliklinik, Abteilung Innere Medizin mit Schwerpunkt Gastroenterologie, and ‡Institut fu¨r Pharmakologie,
`Universita¨tsklinikum Benjamin Franklin, Freie Universita¨t Berlin, Berlin, Germany
`
`Recently, it has been suggested that a similar basic
`Background & Aims: Neuroendocrine cells and tumors
`derived therefrom contain hormone-storing large dense
`fusion machinery may be used by all secretory cells.
`core vesicles and neuron-like small synaptic vesicle Membrane fusion is based primarily on the interaction
`analogues with unknown function. The aim of this study
`between soluble fusogens and their receptors. Soluble
`was to characterize the small synaptic vesicle pathway
`fusogens are the N-ethylmaleimide–sensitive factor
`in detail. Methods: In human pancreatic neuroendo-
`(NSF) and a-, b-, and g-soluble NSF attachment proteins
`crine tumors and corresponding mammalian cell lines,
`(SNAPs).14 NSF binds to membranes when one or more
`the expression of key proteins of regulated secretion
`of
`the SNAPs
`link up to their SNAP receptors
`were detected by immunofluorescence microscopy. Us-
`(SNAREs). An integral membrane protein of a transport
`ing 3H–g-aminobutyric acid (GABA), uptake and release
`vesicle (v-SNARE) pairs with one or more integral mem-
`by small synaptic vesicle analogues were studied. Re-
`brane proteins of the target membrane (t-SNARE). Ac-
`sults: Tumor tissues obtained from 14 patients ex-
`cording to this hypothesis, different v-SNAREs and t-
`pressed key proteins of neurosecretion such as synap-
`SNAREs confer specificity to intracellular fusion events,
`tobrevin, syntaxins, and SNAP 25. These proteins were
`whereas NSF and SNAPs are common to all forms.14–16
`also found in the cell lines AR42J, BON, RIN, and INR.
`The cell lines specifically transported GABA by a low-
`In neurons and chromaffin cells, the v-SNAREs for SSVs
`affinity plasma membrane transporter and showed an
`and LDCVs are synaptobrevin, whereas the t-SNAREs
`adenosine triphosphate–sensitive GABA uptake into
`are syntaxins and SNAP 25 (synaptosomal-associated
`an intracellular compartment. Stored GABA was re-
`protein of 25 kilodaltons).14,17–19
`leased upon stimulation by regulated exocytosis. Elec-
`So far, little information exists concerning the secre-
`trophysiological analyses suggested that calcium-de-
`tory pathway of SSV analogues in neuroendocrine cells.
`pendent secretion was mediated by activation of
`The idea that SSV analogues of pancreatic neuroendocrine
`voltage-dependent calcium channels of mainly the L
`cells may store amino acid transmitters has been sup-
`type, but also of the N and probably the T type. Conclu-
`ported by studies on subcellular fractionation of TCb
`sions: Small synaptic vesicle analogues in neuroendo-
`cells,9 by uptake studies in synaptophysin-immunoiso-
`crine cells and tumors can store and secrete GABA and
`lated vesicles,12 and, most importantly, by the regulated
`probably other amino acid transmitters by regulated
`exocytosis comparable with neurons.
`release of g-aminobutyric acid (GABA) from the amphi-
`crine cell line AR42J.11 The present study was under-
`taken to characterize in detail the SSV pathway. For
`pancreatic neuroendocrine tumors and the corresponding
`mammalian cell lines, we show the expression of SNARE
`proteins found to regulate exocytosis from neurons17,19
`
`N
`
`clinical
`irrespective of
`tumors,
`euroendocrine
`symptoms, express proteins characteristic of secre-
`tory vesicles.1–3 In the past, diagnostic and therapeutic
`efforts have focused on large dense core vesicles (LDCVs),
`the storage organelles for hormones and other polypep-
`tides.2 It turned out that secretion by the LDCV pathway
`is operative regardless of whether patients have clinical
`symptoms.4–6 Besides LDCVs, neuroendocrine cells and
`tumors derived therefrom contain another secretory path-
`way that uses vesicles resembling the small synaptic vesi-
`cles (SSVs) of neurons and thus are termed synaptic-like
`microvesicles or SSV analogues.1,2,7–13
`
`Abbreviations used in this paper: DMEM, Dulbecco’s modified Ea-
`gle medium; EGTA, ethylene glycol-bis(b-aminoethyl ether)-N,N,Nⴕ,Nⴕ-
`tetraacetic acid; GABA, g-aminobutyric acid; ICa, whole-cell calcium
`current; KR-HEPES, Krebs’-Ringer-HEPES; LDCV, large dense core
`vesicles; NSF, N-ethylmaleimide–sensitive factor; SNAP, synapto-
`somal-associated protein; SNARE, synaptosomal-associated protein
`receptor; SSV, small synaptic vessel.
`䉷 1996 by the American Gastroenterological Association
`0016-5085/96/$3.00
`
`/ 5e0d$$0033
`
`04-12-96 15:06:48
`
`gasas
`
`WBS-Gastro
`
`Roxane Labs., Inc.
`Exhibit 1036
`Page 001
`
`

`
`1596 AHNERT–HILGER ET AL.
`
`GASTROENTEROLOGY Vol. 110, No. 5
`
`and nonneoplastic neuroendocrine cells.18,20–22 Further-
`more, we show that mammalian pancreatic neuroendo-
`crine cell lines specifically take up GABA, which is stored
`in SSV analogues and released by regulated exocytosis.
`
`Materials and Methods
`Tissues and Cell Cultures
`
`Human tumor tissues were obtained from 14 patients
`by tumor resection, immediately shock frozen, and used ac-
`cording to the standards set by the Ethical Committee of the
`Klinikum Benjamin Franklin, Freie Universita¨t Berlin. PC12
`cells23 were cultivated in Dulbecco’s modified Eagle medium
`(DMEM) supplemented with 10% horse and 5% fetal calf
`serum and AR42J24 in DMEM supplemented with 20% fetal
`calf serum at 10% CO2. RIN 3825 and INR26 were grown in
`RPMI supplemented with 5% fetal calf serum and 5% calf
`newborn serum, BON cells27 in a 1:1 mixture of DMEM, and
`F12K medium containing 10% fetal calf serum and HeLa cells
`in DMEM containing 10% fetal calf serum in an atmosphere
`of 5% CO2. Primary cultures of mouse hypothalamus were
`prepared and grown as previously described.28
`
`Antibodies
`
`Monoclonal antibody against synaptobrevin II and a
`polyclonal antiserum against synaptobrevin I29 were provided
`by Dr. R. Jahn, Yale University, Howard Hughes Medical
`Institute, New Haven, CT. Polyclonal antisera against human
`synaptobrevin II and syntaxin were kindly provided by Dr.
`T. Rapoport, Harvard University, Boston, MA. Monoclonal
`antibody SY 387 and a polyclonal antiserum against synapto-
`physin10 and monoclonal antibody against cytochrome b56113
`were used as previously described. Monoclonal antibodies
`against SNAP 25 and syntaxin (HPC-1 Barnstacle) were ob-
`tained from Sternberger Monoclonals (Baltimore, MD) or
`Sigma Chemical Co. (Deisenhofen, Germany), respectively. An
`anti-rabbit immunoglobulin (Ig) G antiserum from goat cou-
`pled to Texas Red and an anti-mouse IgG antiserum from
`donkey coupled to Texas Red were obtained from Dianova
`(Hamburg, Germany).
`
`Other Chemicals
`
`Streptolysin O, purified30 and provided by Dr. U. Wel-
`ler, Institut fu¨ r Mikrobiologie, Johannes Gutenberg-Universi-
`ta¨t, Mainz, Germany, was used as described earlier.31,32
`(/)Isradipine was a gift from Sandoz AG (Basel, Switzerland).
`The calcium ionophore A23187, aminooxyacetic acid, gaba-
`culin, betain, b-alanin, and diaminobutyric acid were obtained
`from Sigma Chemical Co. a-Latrotoxin and v-conotoxin
`GVIA were purchased from Alamone Laboratories (Jerusalem,
`Israel). GABA (sp act, 60 Ci/mmol) and 125J–protein A (sp act,
`30 mCi/mg) were obtained from Amersham (Braunschweig,
`Germany).
`
`Immunofluorescence Microscopy and
`Immunoreplica Analysis
`
`Immunofluoresecence microscopy from cryosections of
`human tumor tissues was performed as described.7 The various
`cell lines were grown on coverslips and processed for immu-
`nofluoresecence microscopy as previously described33,34 using
`either Texas Red coupled to anti-mouse or anti-rabbit IgG.
`Immunoreplica analysis was performed as previously de-
`scribed34 except that 125J–protein A was used to detect immu-
`noreactive signals.
`
`GABA Uptake and Secretion
`
`GABA uptake into intact cells was performed in the
`presence of 1 mmol/L aminooxyacetic acid and gabaculine in
`Krebs’-Ringer-HEPES buffer containing (in mmol/L): NaCl,
`130; KCl, 4.7; MgSO4, 1.2; CaCl2, 2.5; glucose, 11; and
`HEPES, 10, pH 7.4 (KR-HEPES buffer), for 30 minutes at
`37⬚C in the presence of the various inhibitors. The incubation
`was stopped by diluting the sample with 500 mL of ice-cold
`KR-HEPES buffer followed by rapid centrifugation. The su-
`pernatant was discarded, and the pellet was washed again with
`KR-HEPES buffer and then dissolved in lysis buffer containing
`(in mmol/L): Tris-HCl, 130; CaCl2, 10; NaCl, 75, pH 8,
`supplemented with 0.4% Triton X-100. One part of the cell
`lysate was used to count the amount of radioactivity; from
`the other part the protein content was determined using the
`bicinchoninic acid method. Values are calculated as picomoles
`per milligram of protein and expressed as percent of the uptake
`in the absence of inhibitors.
`Uptake into permeabilized cells was performed using an
`intracellular buffer consisting of (in mmol/L): sucrose, 200;
`KCl, 50; piperazine-N,N ⴕ-bis(2-ethanesulfonic acid), 20; and
`ethylene glycol-bis(b-aminoethyl ether)-N,N,Nⴕ,Nⴕ-tetraace-
`tic acid (EGTA), 4, pH 7.0, with or without 2 mmol/L Mg/
`adenosine triphosphate (ATP) and 3H-GABA. Incubation with
`SLO followed a protocol given elsewhere.31,32 Values are calcu-
`lated as picomoles per milligram of protein. The uptake in the
`absence of ATP was 100%.
`Secretion was performed from preloaded cells as previously
`described.11
`
`Electrophysiology
`
`For electrophysiological experiments, cells were trans-
`ferred into a perfusion chamber (4 mL/min) and whole-cell
`patch-clamp experiments35 were performed at 37⬚C. Patch pi-
`pettes with pipette resistances of 3–6 MV were prepared from
`borosilicate glass capillaries (Jencons, Leight Buzzard, En-
`gland). Currents were recorded using a List LM/EPC 7 patch-
`clamp amplifier (List Electronics, Darmstadt, Germany) using
`the CED (Cambridge Electronic Design, Cambridge, England)
`interface and software. Voltage-dependent calcium currents
`were routinely elicited from a holding potential of 080 mV
`by either 200-millisecond-long voltage pulses to 10 mV or by
`voltage ramps from 0100 to 100 mV (slope, 1 V/s). Calcium
`
`/ 5e0d$$0033
`
`04-12-96 15:06:48
`
`gasas
`
`WBS-Gastro
`
`Roxane Labs., Inc.
`Exhibit 1036
`Page 002
`
`

`
`May 1996
`
`GABA SECRETION FROM NEUROENDOCRINE CELLS 1597
`
`currents were measured as peak inward currents. Leakage cur-
`rents were determined from the hyperpolarizing part of the
`voltage ramps (0100 to 080 mV) and subtracted offline.
`Statistical values are given as means { SEM.
`To isolate inward currents through voltage-dependent cal-
`cium channels, sodium and potassium were omitted from the
`intracellular and extracellular solutions. Barium was used as
`an extracellular charge carrier. The patch pipettes were filled
`with a high-cesium pipette solution containing (in mmol/L):
`CsCl, 120; MgCl2, 1; Mg ATP, 3; HEPES, 10; and EGTA,
`10; adjusted to pH 7.4 with CsOH at 37⬚C. For the measure-
`ments of barium inward currents through calcium channels,
`an external solution was used containing (in mmol/L): D(0)–
`N-methylglucamine, 120; BaCl2, 10.8; MgCl2, 1; CsCl, 5.4;
`glucose, 10; and HEPES, 10; adjusted to pH 7.4 with HCl at
`37⬚C.
`
`Results
`Expression of SNARE Proteins in
`Pancreatic Neuroendocrine Tumors and
`Mammalian Cell Lines
`
`Regulated secretion involves the interaction be-
`tween the vesicular v-SNARE proteins synaptobrevin and
`plasma membrane t-SNARE proteins syntaxins and SNAP
`25. The expression of synaptobrevin, syntaxins, and SNAP
`25 were analyzed in serial sections of various neuroendo-
`crine tumors of the pancreas. As an example, a pancreatic
`gastrinoma from a 33-year-old patient is shown in Figure
`1. Antibodies against synaptobrevin, SNAP 25, and the
`syntaxins immunoreacted only with the tumor cells but
`not with the surrounding connective tissue. Similar results
`were obtained in 14 other pancreatic neuroendocrine tu-
`mors (Table 1) using monoclonal antibodies against
`syntaxins and synaptobrevin II (not shown). No immuno-
`reactivity was obtained with an antiserum against synapto-
`brevin I (data not shown). Table 1 summarizes the expres-
`sion of SNARE proteins in 14 pancreatic tumors. In
`normal human pancreatic tissue analyzed for comparison,
`only the pancreatic islets but not the surrounding exocrine
`tissue immunoreacted with antibodies against SNAP 25,
`syntaxins, and synaptobrevin including synaptobrevin II
`(data not shown). As previously described, marker proteins
`for either LDCVs such as cytochrome b561 and dopamine
`b-hydroxylase or SSVs such as synaptophysin and protein
`SV2 were expressed in these tumors13 and used for compar-
`ison (see Table 1). Similar results were obtained with 16
`neuroendocrine tumors derived from the midgut (data not
`shown).
`Mammalian cell lines derived from pancreatic neuro-
`endocrine tumors but not HeLa cells also highly ex-
`pressed the SNARE proteins necessary for regulated exo-
`cytosis, as could also be detected by immunofluorescence
`
`microscopy (not shown) and in membranes obtained from
`postnuclear supernatants (Figure 2).
`
`Functional Analysis of SSV Analogues in
`Mammalian Neuroendocrine Pancreatic
`Cell Lines
`
`Because primary cultures from human neuroendo-
`crine tumor tissues were not available, functional studies
`of SSV analogues were performed in mammalian neuro-
`endocrine pancreatic tumor cell lines.
`
`GABA Uptake Into Intact and
`Permeabilized Cells
`
`In a first set of experiments, the GABA uptake
`was characterized using various inhibitors specific for
`different plasma membrane GABA transporters. GABA
`uptake in AR42J cells was driven by a low-affinity trans-
`porter with a median inhibitory concentration of 200
`mmol/L for GABA, betain, and b-alanin. In contrast,
`GABA uptake into INR and RIN cells with a median
`inhibitory concentration of 100 mmol/L for GABA was
`sensitive to b-alanin (median inhibitory concentration,
`50 mmol/L for INR and 200 mmol/L for RIN) and almost
`insensitive to betain, in which millimolar concentrations
`were required for inhibition of uptake (Figure 3). Similar
`results were obtained with BON cells (data not shown).
`diaminobutyric acid, a well-known inhibitor of the neu-
`ronal GABA transporter GAT-136 that efficiently inhib-
`ited GABA uptake into mouse hypothalamic neurons
`(data not shown), was effective only in millimolar concen-
`trations in the neuroendocrine cell lines (Figure 3).
`Transmitter uptake into secretory vesicles is an ATP-
`dependent process. To prove that GABA is really stored
`in an intracellular compartment, cells were permeabilized
`by streptolysin O, washed free of endogenous ATP, and
`then incubated with radiolabeled GABA in the presence
`of ATP and various amounts of unlabeled GABA. ATP
`stimulated GABA uptake 2.5–3-fold (Figure 4)
`in
`AR42J and INR cells and twofold in RIN and BON
`cells (not shown). No ATP-dependent uptake was seen
`in permeabilized HeLa cells under these conditions (not
`shown). Adding carbonyl cyanide p-trifluoromethoxy-
`phenylhydrazone (not shown) or increasing the concen-
`tration of unlabeled GABA (Figure 4) inhibited ATP-
`dependent uptake.
`
`Regulated Secretion of GABA
`
`All four cell lines released GABA in a regulated
`fashion (Figure 5). GABA secretion could be elicited only
`by an elevated potassium concentration or by the calcium
`ionophore A23187 (Figure 5). a-Latrotoxin, a potent
`
`/ 5e0d$$0033
`
`04-12-96 15:06:48
`
`gasas
`
`WBS-Gastro
`
`Roxane Labs., Inc.
`Exhibit 1036
`Page 003
`
`

`
`1598 AHNERT–HILGER ET AL.
`
`GASTROENTEROLOGY Vol. 110, No. 5
`
`Figure 1. Expression of SNARE proteins in a pancreatic neuroendocrine tumor (gastrinoma). Serial sections were fixed and immunostained as
`described in Materials and Methods. Immunofluorescence microscopy was performed using a conventional fluorescence microscope. The
`following antibodies were used: (Aand B) polyclonal antiserum against human synaptobrevin II (dilution, 1:100), (Cand D) monoclonal antibody
`against SNAP 25 (1:1000), and (E and F) a polyclonal antiserum against syntaxin (1:100). The antibodies were detected using a Texas Red–
`labeled goat anti-rabbit or goat anti-mouse antiserum. Immunofluorescence micrographs are shown on the right and corresponding phase
`contrast images on the left. Note that only the tumor tissue is immunostained, whereas the surrounding connective tissue shows no immunoreac-
`tivity.
`
`/ 5e0d$$0033
`
`04-12-96 15:06:48
`
`gasas
`
`WBS-Gastro
`
`Roxane Labs., Inc.
`Exhibit 1036
`Page 004
`
`

`
`May 1996
`
`GABA SECRETION FROM NEUROENDOCRINE CELLS 1599
`
`Table 1. Immunocytochemical Detection of SNARE Proteins and Membrane Proteins of LDCVs and SSVs in Pancreatic
`Neuroendocrine Tumor Tissue
`
`LDCVs
`
`SSV
`analogues
`
`SNARE proteins
`
`v-SNAREs
`
`t-SNAREs
`
`Cytochrome b561
`
`Synaptophysin
`
`Synaptobrevins
`
`SNAP 25
`
`Syntaxins
`
`Functional
`Insulinoma (n Å 1)
`Gastrinomas (n Å 5)
`VIPoma (n Å 1)
`Nonfunctional (n Å 7)
`
`//
`//
`5/5
`//
`//
`6/7
`
`///
`///
`5/5
`///
`///
`7/7
`
`//
`//
`5/5
`//
`//
`7/7
`
`///
`///
`5/5
`//
`///
`7/7
`
`/
`/
`4/5
`//
`/
`6/7
`
`NOTE. Besides tumors with hypersecretory symptoms, a second group of pancreatic tumors with neuroendocrine properties lacking these
`symptoms has been identified using antibodies against secretory vesicle proteins. For clinical diagnostic purposes, these tumors may be
`classified in general as nonfunctional.1–3 Immunofluorescence microscopy was performed as described in Materials and Methods. Intensity of
`the reaction was assessed as follows: ///, very strong; //, strong; /, less strong.
`
`secretagogue for exocytosis by SSVs from neurons,37
`which stimulated GABA secretion from mouse hypotha-
`lamic neurons (not shown), had no effect on GABA secre-
`tion from the neuroendocrine cell lines (not shown).
`Other secretagogues that elicit amylase secretion from
`AR42J cells such as carbachol10 did not stimulate GABA
`secretion from the neuroendocrine cell lines. In the ab-
`sence of extracellular calcium, no regulated GABA secre-
`tion was seen (Figure 6). However, for unknown reasons,
`
`Figure 2. SNARE proteins on membranes of mammalian pancreatic
`neuroendocrine cell lines. Postnuclear supernatants (40 mg of total
`protein per slot) of the cell lines indicated were subjected to sodium
`dodecyl sulfate gel electrophoresis, transferred to polyvinylidene
`difluoride membranes, and probed with the antibodies: a polyclonal
`antiserum against synaptobrevin (dilution, 1:1000), a monoclonal an-
`tibody against SNAP 25 (1:2000), and a monoclonal antibody against
`syntaxin (1:1000). Antibody binding was detected by 125J–protein A.
`Note that SNARE proteins were detected in neuroendocrine cell lines
`but not in HeLa cells.
`
`the absence of extracellular calcium increased basal re-
`lease as previously described for AR42J cells.11
`
`Voltage-Dependent Calcium Channels in
`Mammalian Neuroendocrine Pancreatic
`Cell Lines
`
`All neuroendocrine cell lines studied showed volt-
`age-dependent calcium channels. To characterize the
`different calcium channel subtypes underlying the whole-
`cell calcium current (ICa), we used subtype-specific chan-
`nel inhibitors. Extracellular application of the L-type cal-
`cium channel antagonist isradipine (1 mmol/L) inhibited
`ICa in INR, RIN, and AR42J cells by 87% { 4.1%
`(n Å 6), 81.8% { 3.9% (n Å 4), and 71.3% { 7.8%
`(n Å 5), respectively. During washout, the effect of israd-
`ipine reversed completely. Cumulative application of is-
`radipine and the N-type calcium channel blocker v-
`conotoxin (3 mmol/L) almost completely (95%–100%)
`abolished the inward ICa in INR and RIN cells, whereas
`in AR42J a cadmium-sensitive ICa of approximately
`29.5% { 3.6% (n Å 4) remained after application of
`both antagonists (Figure 7). v-Conotoxin alone reduced
`the control ICa by 19.7% { 7.8% (n Å 3), 13.3% {
`3.8% (n Å 3), and 36.2% { 5.2% (n Å 4) in INR, RIN,
`and AR42J, respectively. This indicates the expression of
`dihydropyridine-sensitive L-type calcium channels and
`an v-conotoxin–sensitive ICa component in all three cell
`lines.
`Because the effects of isradipine and v-conotoxin were
`not or only partially additive, we assume v-conotoxin to
`probably work on a subset of L-type channels containing
`the a1D subunit rather than on N-type channels. The
`a1D subunit found in different neuronal and neuroendo-
`
`/ 5e0d$$0033
`
`04-12-96 15:06:48
`
`gasas
`
`WBS-Gastro
`
`Roxane Labs., Inc.
`Exhibit 1036
`Page 005
`
`

`
`1600 AHNERT–HILGER ET AL.
`
`GASTROENTEROLOGY Vol. 110, No. 5
`
`Figure 4. ATP-dependent GABA uptake into permeabilized AR42J and
`INR cells. Cells were permeabilized with SLO in the absence of ATP
`(see Materials and Methods). Excess ATP was removed by a 20-
`minute incubation at 36⬚C in sucrose KCl. The buffer was replaced
`by fresh KS buffer containing either no ATP or 2 mmol/L Mg/ATP and
`3H-GABA supplemented with the given concentrations of unlabeled
`GABA. The incubation was stopped after 30 minutes at 36⬚C by dilu-
`tion of the samples with ice-cold ATP-free KS buffer and centrifugation
`for 30 seconds at 12,000g.The supernatant was discarded. The cells
`were lysed, and the radioactivity and protein content were determined.
`Uptake in the absence of ATP was set at 100%. Values represent the
`means of three samples { SD. In the presence of 250 mmol/L unla-
`beled GABA, the ATP-dependent uptake was almost completely inhib-
`ited.
`
`crine cell types constitutes high voltage–activated cal-
`cium channels sensitive to both dihydropyridines and
`high concentrations of v-conotoxin.38,39
`BON cells predominantly expressed fast inactivating
`T-type calcium currents that were not significantly af-
`fected by isradipine and v-conotoxin (Figure 8). Only a
`small percentage (15%–25%) of cells showed an addi-
`tional high voltage–activated ICa component. This com-
`ponent was variable in amplitude and increased during
`prolonged cultivation.
`
`Discussion
`Neuroendocrine cells such as pancreatic b cells12,40
`and the rat pheochromocytoma cell line PC 1241 possess
`two types of secretory vesicles: LDCVs and SSV ana-
`logues. Regulated exocytosis from neurons by SSVs17,19,29
`from pancreatic b cells21,22 and chromaffin cells18 by
`LDCVs involves the interaction of SNARE proteins.
`
`Figure 3. Pharmacological characterization of the plasma membrane
`transport of GABA in mammalian pancreatic neuroendocrine cell lines.
`The various cell lines were incubated with 3H-GABA in the absence or
`presence of unlabeled GABA (䊊), b-alanin (䉭), betain (䉱), or diamino-
`butyric acid (䊐) in the concentrations given by the abscissa. The 3H-
`GABA uptake in the absence of inhibitors was set 100%. Values are
`the means of three samples. (A) INR, (B) RIN, (C) AR42J.
`
`SNARE Proteins in Neuroendocrine Tumors
`and Cell Lines
`
`Neuroendocrine pancreatic tumors as well as hu-
`man pancreatic islets express the major proteins of the
`SNARE complex, such as SNAP 25, the syntaxins, and
`
`/ 5e0d$$0033
`
`04-12-96 15:06:48
`
`gasas
`
`WBS-Gastro
`
`Roxane Labs., Inc.
`Exhibit 1036
`Page 006
`
`

`
`May 1996
`
`GABA SECRETION FROM NEUROENDOCRINE CELLS 1601
`
`synaptobevin, including synaptobrevin II. We also found
`these proteins in the pancreatic neuroendocrine cell lines
`AR42J, RIN, INR, and BON. So far, the neuronal
`SNARE proteins have been described only in bovine
`chromaffin cells18 in normal rat pancreatic b cells and
`some pancreatic b cell lines.20–22 Thus, neuroendocrine
`cells share similar SNARE proteins with neurons.
`
`GABA Transport
`
`Neurotransmission is terminated by the rapid re-
`uptake of most neurotransmitters. The reuptake of amino
`acid transmitters GABA and glycine is mediated by
`/
`0
`/Cl
`-dependent transporter family.
`members of the Na
`So far, four GABA transporters (GAT-1–4) with differ-
`ent tissue distribution have been cloned.42 Whereas
`GAT-1 and GAT-4 are exclusively expressed in brain,43,44
`GAT-2 and GAT-3 also occur in peripheral tissues.44
`
`GAT-2 also has a strong homology with the renal betain
`transporter BGT-1, which also transports GABA.45 In
`neuroendocrine cell lines, GABA is transported by a low-
`affinity transporter different from the neuronal types. In
`RIN and INR cells, the pharmacological characterization
`of GABA uptake resembles the b-alanine–sensitive
`GAT-3 transporter.44 Interestingly, GABA transport in
`the amphicrine AR42J cells probably is mediated by a
`transporter similar to the BGT-1 transporter because of
`its sensitivity for betain.45 Work is in progress to charac-
`terize further the probable different GABA transporters
`present in the various neuroendocrine tumor cells. How-
`ever, the presence of at least one GABA transporter in
`neuroendocrine tumor cells and tissues makes them likely
`candidates for the detection by positron emission tomog-
`raphy using specific ligands.
`The GABA taken up by neuroendocrine cell lines is
`stored in an intracellular compartment, most likely the
`SSV analogues. After permeabilization of the plasma
`membrane, ATP- and carbonyl cyanide p-trifluorometh-
`oxy-phenylhydrazone–sensitive uptake of GABA is seen.
`These findings are in line with observations from the
`pancreatic b-cell line bTC3, in which ATP-sensitive
`GABA uptake has been described for immunoisolated
`synaptophysin-containing vesicles.12
`
`Mammalian Neuroendocrine Cell Lines as
`Model Systems
`
`The strongest evidence for a neuron-like function
`of SSV analogues in neuroendocrine cells is provided by
`the regulated secretion of GABA. The stored GABA is
`released upon stimulation with either 50 mmol/L KCl or
`the calcium ionophore A23187 depending on millimolar
`
`Figure 5. GABA secretion from (A) BON and (B) AR42J cells. The
`experiment was performed as in Figure 7. BON or AR42J cells were
`stimulated for 20 minutes at 36⬚C with the amount of secretagogues
`indicated by the abscissa. Release in the absence of secretagogue
`was set 100%. Values represent the means of three samples { SD.
`
`Figure 6. Ca2/-dependent secretion of GABA from mammalian pan-
`creatic neuroendocrine cell lines. Cells were prelabeled with 3H-GABA,
`washed, and incubated for 20 minutes at 36⬚C in the presence or
`absence of Ca2/. Stimulation was performed for 20 minutes at 36⬚C
`with either (A) 50 mmol/L KCl or (B) 50mmol/L A23187 in the pres-
`ence or absence of Ca2/. Release under nondepolarizing conditions
`(5 mmol/L KCl) was set 100%. A stimulated release could be ob-
`served only in the presence of Ca2/. Values are the means of three
`determinations { SD.
`
`/ 5e0d$$0033
`
`04-12-96 15:06:48
`
`gasas
`
`WBS-Gastro
`
`Roxane Labs., Inc.
`Exhibit 1036
`Page 007
`
`

`
`1602 AHNERT–HILGER ET AL.
`
`GASTROENTEROLOGY Vol. 110, No. 5
`
`Figure 7. Pharmacological characterization of ICa in (A) RIN, (B) INR,
`and (C) AR42J cells. ICa was measured from the same cells during
`alternating rectangular voltage pulses (left) and voltage ramps (right).
`Control traces (C) and traces after cumulative application of 3 mmol/
`L v-conotoxin (v-CgTx), 1 mmol/L isradipine (Israd), and 100 mmol/
`L cadmium (Cd2/) are shown.
`
`concentrations of extracellular calcium. So far, functional
`studies with SSVs have been restricted to neurons. The
`presence of both SSV analogues and LDCVs together
`with SNARE proteins in pancreatic neuroendocrine tu-
`mor cell lines makes them useful model systems to study
`aspects of regulated secretion by the two pathways.
`Like neurons, the pancreatic neuroendocrine cell lines
`are equipped with a complete set of voltage-dependent
`calcium channels, probably indicating calcium-depen-
`dent secretion. Therefore, calcium channel blockers with
`some cell-type specificity are likely candidates for future
`diagnostic and therapeutic concepts.
`
`Diagnostic and Therapeutic Impact
`
`The GABA released may stimulate GABAA recep-
`tors recently described in normal and neoplastic neuroen-
`docrine cells.46 Activation of these GABAA receptors re-
`sulted in a depolarization of the membrane, followed by
`a calcium influx, which may in turn modulate secretion
`from LDCVs.47 The role altered GABA secretion plays
`
`Figure 8. Properties of fast inactivating ICa in BON cells. (A) The whole-
`cell I–V relation was constucted from the peak ICa elicited by depolariz-
`ing voltage pulses (100 milliseconds) to potentials indicated on the
`x-axis. The holding potential was 080 mV. (B) The effects of 1 mmol/
`L isradipine (Israd), 3 mmol/L v-conotoxin (v-CgTx), and 30 mmol/L
`nickel (Ni2/) on the control ICa (C) is shown. Currents were activated
`by voltage pulses to 010 mV from a holding potential of 080 mV.
`
`in the functional state and tumor progression of neuroen-
`docrine cells remains to be determined.
`Current studies in our clinical department using radio-
`labeled GABAA-receptor ligands for scintigraphic detec-
`tion of GABA receptors show that GABA receptors can
`be used for tumor imaging in patients with neuroendo-
`crine tumors (B. Wiedenmann, S. Faiss, H. Scheru¨ bl,
`and E.-O. Riecken, unpublished observation, 1995).
`Thus, the molecular characterization of this new secretory
`pathway represents the basis for improved diagnosis and
`probably also treatment of neuroendocrine tumor disease.
`References
`
`1. Wiedenmann B, Franke WW, Kuhn C, Moll R, Gould VE. Synapto-
`physin: a marker protein for neuroendocrine cells and neo-
`plasms. Proc Natl Acad Sci USA 1986;83:3500–3504.
`
`/ 5e0d$$0033
`
`04-12-96 15:06:48
`
`gasas
`
`WBS-Gastro
`
`Roxane Labs., Inc.
`Exhibit 1036
`Page 008
`
`

`
`May 1996
`
`GABA SECRETION FROM NEUROENDOCRINE CELLS 1603
`
`2. Wiedenmann B, Huttner WB. Synaptophysin and chromogranins/
`secretogranins—widespread constituents of distinct types of
`neuroendocrine vesicles and new tools in tumor diagnosis. Virch
`Arch B 1989;8:95–121.
`3. Wiedenmann B, Ba¨der HM, Scheru¨bl H, Fett U, Zimmer T Hamm
`B Kopenhagen K, Riecken EO. Gastroenteropancreatic tumor im-
`aging with somatostatin receptor scintigraphy. Semin Oncol
`1994;21:29–32.
`4. O’Connor DT, Deftos U. Secretion of chromogranin A by peptide-
`producing endocrine neoplasms. N Engl J Med 1986;314:1145–
`1151.
`5. Eriksson B. Tumor markers for pancreatic endocrine tumors, in-
`cluding chromogranins, HCG-alpha and HCG-beta. Front Gas-
`trointest Res 1995;23:121–131.
`6. Solcia E, Sessa F, Rindi G, Villani L, Riva C, Buffa R, Capella C.
`Classification and histogenesis of gastroenteropancreatic endo-
`crine tumours. Eur J Clin Invest 1990;20(Suppl 1):72–81.
`7. Wiedenmann B, Franke WW. Identification and localization of syn-
`aptophysin, an integral membrane glycoprotein of Mr 38,000
`characteristic of presynaptic vesicles. Cell 1985;45:1017–
`1028.
`8. Navone F, Jahn R, Di Gioia G, Stukenbrok H, Greengard P, De
`Camilli P. Protein p 38: an integral membrane protein specific
`for small vesicles of neurons and neuroendocrine cells. J Cell
`Biol 1986;103:2511–2527.
`9. Reetz A, Solimena M, Matteoli M, Folli M, Takei K, DeCamilli
`P. GABA and pancreatic b-cells: co-localization of glutamic acid
`decarboxylase (GAD) and GABA with synaptic-like microvesicles
`suggests their role in GABA storage and secretion. EMBO J 1991;
`10:1275–1284.
`10. Rosewicz S, Vogt D, Harth N, Grund C, Franke WW, Ruppert
`S, Schweitzer E, Riecken EO, Wiedenmann B. An amphicrine
`pancreatic cell line: AR42J cells combine exocrine and neuroen-
`docrine properties. Eur J Cell Biol 1992;59:80–91.
`11. Ahnert-Hilger G, Wiedenmann B. The amphicrine pancreatic cell
`line AR42J secretes GABA and amylase by separate regulated
`pathways. FEBS Lett 1992;314:41–44.
`12. Thomas-Reetz A, Hell JW, During MJ, Walch-Solimena C, Jahn R,
`DeCamilli P. A g-aminobutyric acid transporter driven by a proton
`pump is present in synaptic-like microvesicles of pancreatic b
`cells. Proc Natl Acad Sci USA 1993;90:5317–5321.
`13. Ahnert-Hilger G, Grube K, Kvols L, Lee I, Mo¨nch E, Riecken EO,
`Schmitt L, Wiedenmann B. Gastroenteropancreatic neuroendo-
`crine tumours contain a common set of synaptic vesicle proteins
`and amino acid neurotransmitters. Eur J Cancer 1993;9A:1982–
`1984.
`14. So¨llner T, Whiteheart SW, Brunner M, Erdjument-Bromage H, Ger-
`omanos S, Tempst P, Rothman JE. SNAP receptors implicated
`in vesicle targeting and fusion. Nature 1993;362:318–324.
`15. Rothman JE, Orci L. Molecular dissection of the secretory path-
`way. Nature 1992;355:409–415.
`16. Rothman JE. Mechanisms of intracellular protein transport. Na-
`ture 1994;372:55–63.
`17. Su¨dhof TC, DeCamilli P, Niemann H, Jahn R. Membrane fusion
`machinery: insights from synaptic proteins. Cell 1993;75:1–4.
`18. Hodel A, Scha¨fer T, Gerosa D, Burger MM. In chromaffin cells, the
`mammalian sec1p-homologue is a syntaxin 1A-binding protein
`associated with chromaffin granules. J Biol Chem 1994;259:
`8623–8626.
`19. Su¨dhof TC. The synaptic vesicle cycle: a cascade of protein-
`protein interactions. 1995;375:645–653.
`20. Jacobsson G, Bean AJ, Scheller RH, Juntti-Berggren L, Deeney
`JT, Berggren PO, Meister B. Identification of synaptic proteins
`and their isoform mRNAs in compartments of pancreatic endo-
`crine cells. Proc Natl Acad Sci USA 1994;91:12487–12491.
`21. Sadoul K, Lang J, Montecucco C, Weller U, Catsicas

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket